Cytomx Therapeutics, Inc. · NASDAQ:CTMX
Ogden Christopher sold 1,624 Cytomx Therapeutics, Inc. shares (Form 4)
Traded Jun 15, 2026 · Filed Jun 17, 2026
On Jun 15, 2026, Ogden Christopher (Chief Financial Officer) sold 1,624 Cytomx Therapeutics, Inc. shares at US$3.05 for US$4,953, leaving 295,324 shares. Filed Jun 17, 2026 (Form 4).
- Sold
- 1,624 shares
- Price
- US$3.05
- Value
- US$4,953
- Holding after
- 295,324 shares
- Trading plan
- No
- Role
- Chief Financial Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 15, 2026 | Common Stock | Sale | 1,624 | US$3.05 | 295,324 | Direct |
Source
Related
- Cytomx Therapeutics, Inc.
- Ogden Christopher
- Cytomx Therapeutics, Inc. shareholders
- Form 4/A · McCarthy Sean A. · Oct 16, 2026
- Schedule 13G/A · Kynam Capital Management, LP · Aug 14, 2026
- Schedule 13G/A · Point72 Asset Management, L.P. · Aug 14, 2026
- Schedule 13G · State Street Corp · Aug 7, 2026
- Form 4 · Carvajal Alejandra · Aug 5, 2026